Ernst Schönbrunn

Person

Tampa, FL, US

People

Patents Grantslast 30 patents

Information Patent Grant
BRD4-JAK2 inhibitors
- Patent number 12,187,686
- Issue date Jan 7, 2025
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Ernst Schönbrunn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
BRD4-kinase inhibitors as cancer therapeutics
- Patent number 11,643,396
- Issue date May 9, 2023
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Ernst Schönbrunn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
BRD4-kinase inhibitors as cancer therapeutics
- Patent number 10,738,016
- Issue date Aug 11, 2020
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Ernst Schönbrunn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Potent dual BRD4-kinase inhibitors as cancer therapeutics
- Patent number 10,526,291
- Issue date Jan 7, 2020
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Ernst Schönbrunn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of Rho associated protein kinases (ROCK) and methods of use
- Patent number 9,808,447
- Issue date Nov 7, 2017
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Ernst Schonbrunn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aurora kinase inhibitors and methods of making and using thereof
- Patent number 9,597,329
- Issue date Mar 21, 2017
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Said M. Sebti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of rho associated protein kinases (ROCK) and methods of use
- Patent number 9,409,868
- Issue date Aug 9, 2016
- H. Lee Moffin Cancer Center and Research Institute, Inc.
- Ernst Schonbrunn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aurora kinase inhibitors and methods of making and using thereof
- Patent number 9,249,124
- Issue date Feb 2, 2016
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Said M. Sebti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPOUNDS FOR TARGETED DEGRADATION OF TAF1
- Publication number 20240398800
- Publication date Dec 5, 2024
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Justin LOPCHUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TAF1 INHIBITORS
- Publication number 20240150333
- Publication date May 9, 2024
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Ernst SCHONBRUNN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS AND DEGRADERS OF JANUS KINASE 2
- Publication number 20240140952
- Publication date May 2, 2024
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Nicholas LAWRENCE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC COMPOUNDS AND METHODS
- Publication number 20240002339
- Publication date Jan 4, 2024
- Regents of the University of Minnesota
- Ingrid Gunda Georg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MERGED SCAFFOLD TAF1 INHIBITORS
- Publication number 20240002378
- Publication date Jan 4, 2024
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Justin M. LOPCHUK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRD4-JAK2 INHIBITORS
- Publication number 20220119370
- Publication date Apr 21, 2022
- H. LEE MOFFITT CANCER CENTER AND RESEACH INSTITUTE, INC.
- Ernst SCHÖNBRUNN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRD4-JAK2 INHIBITORS
- Publication number 20210355088
- Publication date Nov 18, 2021
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Ernst SCHÖNBRUNN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS
- Publication number 20200407328
- Publication date Dec 31, 2020
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Ernst Schönbrunn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POTENT DUAL BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS
- Publication number 20190055203
- Publication date Feb 21, 2019
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Ernst Schönbrunn
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS
- Publication number 20180290984
- Publication date Oct 11, 2018
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Ernst Schönbrunn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF RHO ASSOCIATED PROTEIN KINASES (ROCK) AND METHODS OF USE
- Publication number 20170049760
- Publication date Feb 23, 2017
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Ernst Schonbrunn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AURORA KINASE INHIBITORS AND METHODS OF MAKING AND USING THEREOF
- Publication number 20170000787
- Publication date Jan 5, 2017
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Said M. Sebti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF RHO ASSOCIATED PROTEIN KINASES (ROCK) AND METHODS OF USE
- Publication number 20140336440
- Publication date Nov 13, 2014
- Ernst Schonbrunn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AURORA KINASE INHIBITORS AND METHODS OF MAKING AND USING THEREOF
- Publication number 20140057913
- Publication date Feb 27, 2014
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Said M. Sebti
- G01 - MEASURING TESTING

Ernst Schönbrunn

Person

Patents Grantslast 30 patents

BRD4-JAK2 inhibitors

BRD4-kinase inhibitors as cancer therapeutics

BRD4-kinase inhibitors as cancer therapeutics

Potent dual BRD4-kinase inhibitors as cancer therapeutics

Inhibitors of Rho associated protein kinases (ROCK) and methods of use

Aurora kinase inhibitors and methods of making and using thereof

Inhibitors of rho associated protein kinases (ROCK) and methods of use

Aurora kinase inhibitors and methods of making and using thereof

Patents Applicationslast 30 patents

COMPOUNDS FOR TARGETED DEGRADATION OF TAF1

TAF1 INHIBITORS

INHIBITORS AND DEGRADERS OF JANUS KINASE 2

THERAPEUTIC COMPOUNDS AND METHODS

MERGED SCAFFOLD TAF1 INHIBITORS

BRD4-JAK2 INHIBITORS

BRD4-JAK2 INHIBITORS

BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS

POTENT DUAL BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS

BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS

INHIBITORS OF RHO ASSOCIATED PROTEIN KINASES (ROCK) AND METHODS OF USE

AURORA KINASE INHIBITORS AND METHODS OF MAKING AND USING THEREOF

INHIBITORS OF RHO ASSOCIATED PROTEIN KINASES (ROCK) AND METHODS OF USE

AURORA KINASE INHIBITORS AND METHODS OF MAKING AND USING THEREOF